The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice

Claudia Lanterna(Vita-Salute San Raffaele University), Andrea Musumeci(Vita-Salute San Raffaele University), Laura Raccosta(Vita-Salute San Raffaele University), Gianfranca Corna(Vita-Salute San Raffaele University), Marta Angiola Moresco(Vita-Salute San Raffaele University), Daniela Maggioni(Vita-Salute San Raffaele University), Raffaella Fontana(Vita-Salute San Raffaele University), Claudio Doglioni(Vita-Salute San Raffaele University), Claudio Bordignon(Vita-Salute San Raffaele University), Catia Traversari(MolMed (Italy)), Vincenzo Russo(Vita-Salute San Raffaele University)
Cancer Immunology Immunotherapy
August 12, 2016
10.1007/s00262-016-1884-8
Cited by 54Open Access
Full Text

Abstract

Related Papers

T cell receptor antagonist peptides induce positive selection
Kristin A. Hogquist, Stephen C. Jameson, William R. Heath et al.|Cell|1994|2.9k
Regulation of immune responses by L-arginine metabolism
Vincenzo Bronte, Paola Zanovello|Nature reviews. Immunology|2005|1.7k
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel, Antoine Tesnière, Guido Kroemer|Nature reviews. Immunology|2006|1.3k
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
Sawsan Youssef, Olaf Stüve, Juan C. Patarroyo et al.|Nature|2002|1.1k
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
John A. Oates, Alastair J.J. Wood, Scott M. Grundy|New England Journal of Medicine|1988|764